MLSS
Milestone Scientific Inc.
NYSE AmericanUSDEQUITY
Healthcare
DELAYED
Neutral
-3/100
Last price
0.37
▲ 0.01 (1.38%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
0.36
Day high
0.39
Day low
0.35
Volume
122.95K
Market cap
$33.26M
P/E (TTM)
—
52W range
0.22 – 0.60
Trailing performance
Returnvs SPY
1W
-9.76%
-11.7%
1M
-21.28%
-22.4%
3M
+8.82%
+4.3%
6M
+32.14%
+14.0%
YTD
+37.04%
+22.8%
1Y
-15.91%
-32.3%
3Y
-59.78%
-142.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on MLSS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
14.21M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Oct 24, 25 | BP4 S.R.L. Beneficial Owner of more than 10% of a Class of Security |
SELL | 194.43K | $84.88K | Direct |
| Oct 21, 25 | BP4 S.R.L. Beneficial Owner of more than 10% of a Class of Security |
SELL | 64.03K | $28.47K | Direct |
| Oct 14, 25 | BP4 S.R.L. Beneficial Owner of more than 10% of a Class of Security |
SELL | 50.16K | $27.27K | Direct |
| Oct 8, 25 | BP4 S.R.L. Beneficial Owner of more than 10% of a Class of Security |
SELL | 40.00K | $18.45K | Direct |
| Oct 3, 25 | BP4 S.R.L. Beneficial Owner of more than 10% of a Class of Security |
SELL | 19.21K | $8.64K | Direct |
| Sep 11, 25 | BP4 S.R.L. Beneficial Owner of more than 10% of a Class of Security |
SELL | 10.00K | $5.94K | Direct |
| Jul 17, 25 | BP4 S.R.L. Beneficial Owner of more than 10% of a Class of Security |
SELL | 10.00K | $6.40K | Direct |
| Jul 8, 25 | BP4 S.R.L. Beneficial Owner of more than 10% of a Class of Security |
SELL | 92.90K | $62.80K | Direct |
| Jun 30, 25 | BP4 S.R.L. Beneficial Owner of more than 10% of a Class of Security |
SELL | 27.88K | $21.88K | Direct |
| Jun 18, 25 | BP4 S.R.L. Beneficial Owner of more than 10% of a Class of Security |
SELL | 11.75K | $10.49K | Direct |
| Jun 11, 25 | BP4 S.R.L. Beneficial Owner of more than 10% of a Class of Security |
SELL | 23.80K | $21.46K | Direct |
| Jun 10, 25 | BP4 S.R.L. Beneficial Owner of more than 10% of a Class of Security |
SELL | 50.37K | $45.71K | Direct |
| Jun 6, 25 | BP4 S.R.L. Beneficial Owner of more than 10% of a Class of Security |
SELL | 87.06K | $78.71K | Direct |
| Jun 4, 25 | BP4 S.R.L. Beneficial Owner of more than 10% of a Class of Security |
SELL | 14.00K | $12.96K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BP4 S.R.L. |
Beneficial Owner of more than 10% of a Class of Security | 8.90M | Sale |
MCGEEHAN MICHAEL |
Director | 575.27K | Sale |
OSSER LEONARD A |
Director | 4.61M | Sale |
Fundamentals
Market cap$33.26M
Enterprise value$31.13M
Revenue (TTM)$9.42M
Gross profit$6.62M
EBITDA$-4.03M
Net income$-4.14M
EPS (TTM)$-0.04
Free cash flow$981.64K
Total cash$2.07M
Total debt$615.70K
Book value / share$0.04
Shares outstanding90.61M
Float72.86M
Short % of float0.12%
Dividend yield0.00%
Beta (5Y)1.13
Valuation & profitability ratios
Trailing P/E—
Forward P/E-10.49
PEG ratio—
Price / sales—
Price / book9.41
EV / revenue3.30
EV / EBITDA-7.73
Gross margin70.23%
Operating margin-37.36%
Profit margin-43.98%
Return on equity-121.67%
Return on assets-31.28%
Debt / equity17.74
Current ratio1.85
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $8.97M | $8.63M | $9.83M | $8.81M | +4.0% |
| Operating revenue | $8.97M | $8.63M | $9.83M | $8.81M | +4.0% |
| Cost of revenue | $2.57M | $2.20M | $3.03M | $3.91M | +16.9% |
| Gross profit | $6.41M | $6.43M | $6.79M | $4.90M | -0.4% |
| Research & development | $449.47K | $858.77K | $701.38K | $1.15M | -47.7% |
| Selling, general & admin | $11.58M | $12.30M | $13.14M | $12.51M | -5.8% |
| Total operating expense | $12.10M | $13.19M | $13.90M | $13.73M | -8.2% |
| Operating income | -$5.70M | -$6.76M | -$7.11M | -$8.83M | +15.7% |
| Net interest income | -$25.60K | $60.27K | $125.53K | $54.61K | -142.5% |
| Pre-tax income | -$5.72M | -$4.71M | -$6.98M | -$8.77M | -21.4% |
| Tax provision | $0 | $0 | $0 | $0 | — |
| Net income | -$5.72M | -$4.71M | -$6.93M | -$8.71M | -21.4% |
| Net income to common | -$5.72M | -$4.71M | -$6.93M | -$8.71M | -21.4% |
| Basic EPS | -0.07 | -0.06 | -0.10 | -0.12 | -16.7% |
| Diluted EPS | -0.07 | -0.06 | -0.10 | -0.12 | -16.7% |
| EBIT | -$5.70M | -$6.76M | -$7.11M | -$8.83M | +15.7% |
| EBITDA | -$5.51M | -$6.62M | -$6.96M | -$8.68M | +16.8% |
| Basic shares | 82.06M | 79.79M | 72.78M | 70.61M | +2.8% |
| Diluted shares | 82.06M | 79.79M | 72.78M | 70.61M | +2.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $1.11M | $3.26M | $2.98M | $8.72M | -65.8% |
| Cash & short-term investments | $1.11M | $3.26M | $5.95M | $8.72M | -65.8% |
| Accounts receivable | $680.62K | $475.38K | $312.66K | $693.72K | +43.2% |
| Inventory | $3.78M | $3.71M | $2.64M | $1.79M | +1.8% |
| Total current assets | $7.48M | $9.29M | $10.79M | $12.97M | -19.5% |
| Property, plant & equipment | $225.38K | $337.96K | $374.26K | $479.48K | -33.3% |
| Goodwill & intangibles | $79.06K | $148.40K | $178.64K | $227.96K | -46.7% |
| Total assets | $7.81M | $9.80M | $11.37M | $13.70M | -20.3% |
| Total current liabilities | $4.13M | $3.74M | $3.08M | $3.30M | +10.3% |
| Long-term debt | $800.00K | — | — | — | — |
| Total debt | $1.02M | $349.05K | $395.98K | $497.04K | +192.3% |
| Total liabilities | $4.99M | $3.96M | $3.36M | $3.70M | +26.0% |
| Retained earnings | -$133.78M | -$128.05M | -$123.34M | -$116.41M | -4.5% |
| Shareholder equity | $2.81M | $5.83M | $8.01M | $10.23M | -51.8% |
| Working capital | $3.35M | $5.54M | $7.72M | $9.67M | -39.6% |
| Net tangible assets | $2.73M | $5.68M | $7.83M | $10.00M | -51.9% |
| Shares issued | 80.49M | 78.05M | 75.88M | 69.31M | +3.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$5.72M | -$4.71M | -$6.98M | -$8.77M | -21.4% |
| Depreciation & amortisation | $185.66K | $134.84K | $150.77K | $144.38K | +37.7% |
| Stock-based compensation | $1.68M | $1.71M | $1.88M | $1.82M | -1.7% |
| Change in working capital | -$93.85K | -$631.00K | -$1.40M | -$549.72K | +85.1% |
| Operating cash flow | -$2.92M | -$2.92M | -$5.33M | -$6.03M | +0.1% |
| Capital expenditure | -$15.12K | -$10.12K | -$4.88K | -$8.53K | -49.4% |
| Investing cash flow | -$15.12K | $2.97M | -$2.97M | -$8.53K | -100.5% |
| Financing cash flow | $786.34K | $233.77K | $2.56M | -$8.54K | +236.4% |
| Free cash flow | -$2.93M | -$2.93M | -$5.33M | -$6.04M | -0.1% |
| End cash position | $1.11M | $3.26M | $2.98M | $8.72M | -65.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $2.84M | $2.16M | $2.06M | $2.36M | $2.32M | — | +31.4% |
| Operating revenue | $2.84M | $2.16M | $2.06M | $2.36M | $2.32M | — | +31.4% |
| Cost of revenue | $930.87K | $598.01K | $556.31K | $719.25K | $705.86K | — | +55.7% |
| Gross profit | $1.91M | $1.56M | $1.50M | $1.64M | $1.62M | — | +22.1% |
| Research & development | $6.61K | $0 | $12.33K | $16.23K | $51.79K | — | — |
| Selling, general & admin | $2.95M | $2.37M | $2.55M | $2.74M | $3.03M | — | +24.1% |
| Total operating expense | $2.97M | $2.39M | $2.58M | $2.78M | $3.10M | — | +24.2% |
| Operating income | -$1.06M | -$828.08K | -$1.08M | -$1.13M | -$1.48M | — | -28.2% |
| Net interest income | $2.23K | -$11.77K | -$10.90K | -$19.49K | $1.52K | — | +119.0% |
| Pre-tax income | -$1.06M | -$839.85K | -$1.09M | -$1.15M | -$1.48M | — | -26.1% |
| Tax provision | $0 | $0 | $0 | $0 | $0 | — | — |
| Net income | -$1.06M | -$839.85K | -$1.09M | -$1.15M | -$1.48M | — | -26.1% |
| Net income to common | -$1.06M | — | — | — | — | — | — |
| Basic EPS | -0.01 | -0.01 | — | -0.01 | -0.02 | -0.02 | 0.0% |
| Diluted EPS | -0.01 | -0.01 | — | -0.01 | -0.02 | -0.02 | 0.0% |
| EBIT | -$1.06M | -$828.08K | -$1.08M | -$1.13M | -$1.48M | — | -28.2% |
| EBITDA | -$1.01M | -$780.05K | -$1.03M | -$1.10M | -$1.43M | — | -29.8% |
| Basic shares | 93.13M | 85.04M | — | 82.32M | 82.05M | 81.85M | +9.5% |
| Diluted shares | 93.13M | 85.04M | — | 82.32M | 82.05M | 81.85M | +9.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.07M | $1.19M | $1.11M | $1.35M | $1.27M | +73.0% |
| Cash & short-term investments | $2.07M | $1.19M | $1.11M | $1.35M | $1.27M | +73.0% |
| Accounts receivable | $1.00M | $555.77K | $680.62K | $706.92K | $684.20K | +80.5% |
| Inventory | $3.09M | $3.49M | $3.78M | $4.13M | $3.90M | -11.6% |
| Total current assets | $8.12M | $7.35M | $7.48M | $8.11M | $7.63M | +10.4% |
| Property, plant & equipment | $161.59K | $191.53K | $225.38K | $255.73K | $282.36K | -15.6% |
| Goodwill & intangibles | $44.86K | $61.96K | $79.06K | $96.04K | $113.49K | -27.6% |
| Total assets | $8.35M | $7.96M | $7.81M | $8.49M | $8.05M | +4.8% |
| Total current liabilities | $4.40M | $4.86M | $4.13M | $5.03M | $3.77M | -9.5% |
| Long-term debt | $465.98K | $800.00K | $800.00K | $800.00K | $800.00K | -41.8% |
| Total debt | $615.70K | $985.35K | $1.02M | $1.05M | $1.09M | -37.5% |
| Total liabilities | $4.88M | $5.68M | $4.99M | $5.94M | $4.71M | -14.1% |
| Retained earnings | -$135.67M | -$134.62M | -$133.78M | -$132.68M | -$131.53M | -0.8% |
| Shareholder equity | $3.47M | $2.28M | $2.81M | $2.55M | $3.34M | +51.9% |
| Working capital | $3.72M | $2.50M | $3.35M | $3.08M | $3.86M | +49.1% |
| Net tangible assets | $3.43M | $2.22M | $2.73M | $2.45M | $3.23M | +54.1% |
| Shares issued | 88.76M | 80.49M | 80.49M | 78.59M | 78.59M | +10.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$1.06M | -$839.85K | -$1.09M | -$1.15M | -$1.48M | -26.1% |
| Depreciation & amortisation | $48.90K | $48.03K | $50.29K | $39.08K | $50.98K | +1.8% |
| Stock-based compensation | $399.20K | $312.16K | $534.37K | $363.08K | $159.68K | +27.9% |
| Change in working capital | -$2.64K | $562.49K | -$542.76K | $833.57K | -$701.50K | -100.5% |
| Operating cash flow | -$585.13K | $86.84K | -$226.13K | $81.78K | -$1.76M | -773.8% |
| Capital expenditure | -$4.14K | -$1.63K | -$3.12K | -$6.23K | -$4.47K | -153.6% |
| Investing cash flow | -$4.14K | -$1.63K | -$3.12K | -$6.23K | -$4.47K | -153.6% |
| Financing cash flow | $1.46M | -$3.43K | -$3.41K | -$4.56K | $796.58K | +42,737.5% |
| Free cash flow | -$589.27K | $85.21K | -$229.25K | $75.54K | -$1.77M | -791.5% |
| End cash position | $2.07M | $1.19M | $1.11M | $1.35M | $1.27M | +73.0% |
Options analytics
Put / call volume
2.00
Put-heavy session
Put / call open interest
0.46
Positioning, not flow
Max pain
1.00
+172.4% from spot
ATM implied vol
50.0%
Nearest strike to spot
Skew (10% OTM)
-50.0%
Calls bid over puts
Call volume
4
Contracts, this expiry
Put volume
8
Contracts, this expiry
Heaviest call OI
1.00
13 contracts
Heaviest put OI
7.50
3 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.01 | -0.01 | 0.0% |
| Mar 2026 | -0.02 | -0.01 | +33.3% |
| Dec 2025 | -0.02 | -0.01 | +33.3% |
| Sep 2025 | -0.01 | -0.01 | 0.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.01 | 2 | $2.41M | +2.0% |
| Next quarter | -0.01 | 2 | $2.56M | +24.6% |
| Current year | -0.04 | 2 | $9.97M | +11.1% |
| Next year | -0.04 | 2 | $11.35M | +13.8% |
Analyst targets & ownership
Mean target$1.25
High target$1.50
Low target$1.00
Implied upside240.60%
Analyst count2
ConsensusNONE
Strong buy / Buy1 / 1
Hold0
Sell / Strong sell0 / 0
Held by insiders16.01%
Held by institutions5.30%
Institutions holding29
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.40
-7.79% from price
SMA 20
0.41
-8.75% from price
SMA 50
0.45
-16.93% from price
SMA 100
0.41
-10.12% from price
SMA 200
0.35
+5.29% from price
EMA 12
0.40
-7.21% from price
EMA 26
0.41
-11.37% from price
EMA 50
0.42
-12.84% from price
RSI (14)
37.0
Neutral
MACD (12,26,9)
-0.02
Hist -0.00
ATR (14)
0.03
9.46% of price
Realised vol 30D
64.0%
Annualised
Bollinger upper
0.44
20, 2σ
Bollinger lower
0.37
20, 2σ
50 / 200 cross
Golden
0.45 vs 0.35
Trend bias
Above 200
+5.29%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.05
More volatile than market
Correlation to SPY
0.16
Largely independent
Realised vol 30D
64.0%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-53.7%
Peak to trough
Max drawdown 5Y
-90.8%
Peak to trough
ATR 14
0.03
9.46% of price
Beta (reported)
1.13
5Y monthly, from filing
Short interest
Shares short
91.29K
Prior 209.36K
Change vs prior
-56.4%
Shorts covering
% of float
0.12%
Normal
% of shares out
0.10%
Against total outstanding
Days to cover
0.9
Liquid
Float
72.86M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 20, 25 | Benchmark | MAINTAINED | Speculative Buy | Speculative Buy |
| Nov 20, 24 | Benchmark | MAINTAINED | Speculative Buy | Speculative Buy |
| Oct 10, 24 | Benchmark | INITIATED | — | Speculative Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split1:3
Split dateJan 14, 2004
SEC filings
Offering Registrations
S-3/A · 2026-09-18
Offering Registrations
S-3 · 2026-09-08
Periodic Financial Reports
10-Q · 2026-08-13
Corporate Changes & Voting Matters
8-K · 2026-07-31
Corporate Changes & Voting Matters
8-K · 2026-07-29
Corporate Changes & Voting Matters
8-K · 2026-06-25
Proxy Statements
DEF 14A · 2026-06-22
Proxy Statements
PRER14A · 2026-06-10
Headlines
Milestone Scientific Highlights Building a Scalable Growth Platform for CompuFlo® Medical Business
GlobeNewswire · 8d ago
Milestone Scientific Announces Pain and Spine Specialists and Dr. Sudhir Rao as CompuFlo® Development Partner and Advisor
GlobeNewswire · 21d ago
Milestone Scientific Achieves Debt-Free Balance Sheet Through Debt-to-Equity Conversion by Three Directors
GlobeNewswire · 42d ago
Milestone Scientific Inc (MLSS) (Q2 2026) Earnings Call Highlights: Revenue Surges 22% on ...
GuruFocus.com · 54d ago
Milestone Scientific Inc. Q2 2026 Earnings Call Summary
Moby · 54d ago
Milestone Scientific Reports Financial Results for Second Quarter 2026
GlobeNewswire · 54d ago
Earnings To Watch: Milestone Scientific Inc (MLSS) Q2 2026 -- GF Value Sees 13% Upside
GuruFocus.com · 55d ago
Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call
GlobeNewswire · 62d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.